Qiagen is a holding company. Through its subsidiaries, Co. is a global provider of Sample to Insight solutions that enable customers to gain molecular insights from samples containing the building blocks of life. Co.'s sample technologies isolate and process deoxyribonucleic acid, ribonucleic acid and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in workflows. Co. provides solutions to customers in Molecular Diagnostics and Life Sciences. The QGEN stock yearly return is shown above.
The yearly return on the QGEN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the QGEN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|